English | Español
Jamie Barrand | Dec 1, 2015

Synthetic Biologics releases study results for SYN-004
Jamie Barrand | Dec 1, 2015

Study looks at link between pollution, heart disease in diabetic women
Jamie Barrand | Dec 1, 2015

Empliciti approved by FDA for treatment of multiple myeloma
Kerry Goff | Dec 1, 2015

University of Toronto's new ALS research may have pinpointed cause of disease
Jamie Barrand | Nov 26, 2015

Intravenous form of ibuprofen now available in Australia
Jamie Barrand | Nov 25, 2015

CRS-207 designated as orphan drug for mesothelioma treatment
Jamie Barrand | Nov 25, 2015

Opdivo becomes sole PD-1 inhibitor to increase survival rate of renal cell carcinoma patients
Kim Sunderland | Nov 25, 2015

AMA Interaction Studio allows next-gen collaboration between physicians, entrepreneurs

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’